• Acetylspiramycin: A Smarter MIC Study Framework

  2026-09-22

  Acetylspiramycin (Spiramycin B) offers a practical way to refine macrolide susceptibility studies under rising resistance. This article translates recent Mycoplasma pneumoniae findings into assay design, interpretation, and host-pathogen research decisions.

• FKBP9, ER Stress, and Glioblastoma Resistance

  2026-09-21

  Xu et al. identify FKBP9 as an oncogenic factor that supports glioblastoma growth while buffering cells against endoplasmic reticulum stress. Their integrated clinical, cellular, mechanistic, and in vivo experiments connect FKBP9 with ASK1–p38MAPK signaling, the IRE1α–XBP1 unfolded protein response, and resistance to ER stress inducers.

• Carrier-Free Triterpene Prodrug for OSCC

  2026-09-21

  This ACS Applied Materials & Interfaces study developed a carrier-free prodrug assembled from glycyrrhetinic acid and ginsenoside Rh2 for targeted oral squamous cell carcinoma therapy. Its design combines glucose-associated uptake, ROS-responsive thioketal cleavage, and glycyrrhetinic-acid-driven oxidative amplification to promote synergistic apoptosis while avoiding a separate nanocarrier.

• SB 225002: CXCR2 Antagonist for Neutrophil Research

  2026-09-20

  SB 225002, also called SB225002, is a selective non-peptide CXCR2 antagonist for studying IL-8- and GROα-driven neutrophil trafficking. Its reported 22 nM IL-8 binding benchmark and greater than 150-fold CXCR2 preference over CXCR1 support receptor-dissection studies, but they do not establish activity against CXCR1-dependent tumor-cell signaling.

• ABT-199 (Venetoclax) Apoptosis Workflow

  2026-09-19

  Build a dependency-guided apoptosis workflow with ABT-199 (Venetoclax), from DMSO stock preparation through orthogonal cell-death validation. Its strong BCL-2 selectivity makes it especially useful for B-cell models, while the reference study provides a practical warning: senescent solid-tumor cells may depend on different anti-apoptotic proteins.

• Dendritic Cell mRNA Electroporation: Evidence and Design

  2026-09-18

  This study showed that electroporating mature dendritic cells can improve the combined performance of mRNA delivery, cell survival, antigen expression, and T-cell stimulation compared with electroporating immature cells. Its pulse-comparison strategy provides a useful framework for interpreting reporter fluorescence alongside phenotype and immune function rather than treating transfection efficiency as the sole endpoint.

• Indomethacin (A8449): Practical Research Workflow

  2026-09-18

  Indomethacin (SKU A8449) provides a defined cyclooxygenase perturbation tool for inflammation research, with additional utility in PPAR-related and membrane-focused experiments. This guide addresses preparation, solvent control, QC, and interpretation boundaries; it should not be treated as a universal cellular dosing protocol or a substitute for model-specific validation.

• Indomethacin: Practical Protocols for Inflammation Research

  2026-09-17

  Indomethacin provides a standardized way to probe cyclooxygenase-dependent inflammatory responses and exploratory PPAR or membrane phenotypes in controlled assays. It is not water-soluble, and its product-dossier activities should not be treated as a universal cellular dose or as evidence for disease-specific efficacy.

• Removing Pollen Interference in EEM Bioaerosol Detection

  2026-09-17

  Zhang and colleagues developed a spectral preprocessing and random forest workflow to reduce pollen interference during hazardous bioaerosol classification by excitation–emission matrix fluorescence spectroscopy. Fast Fourier transformation produced the strongest reported improvement, raising classification accuracy to 89.24% and enabling clearer discrimination of several pathogenic bacteria and toxins.

• Dihydroartemisinin: Applied Research Workflows

  2026-09-16

  Build reproducible Dihydroartemisinin assays for parasite, mesangial-cell, inflammatory, and signaling studies with controlled solvent handling and light protection. A stage-aware malaria workflow inspired by the phebestin study helps distinguish compound activity from assay artifacts without treating results from different molecules as interchangeable.

• Pollen Interference in Hazardous Bioaerosol EEM

  2026-09-16

  A 2024 Molecules study shows that pollen fluorescence can interfere with the classification of hazardous bioaerosol components using excitation–emission matrix spectroscopy. Combining spectral transformations, particularly fast Fourier transform processing, with random forest classification improved recognition and provided a computational strategy for reducing pollen-related misclassification.

• OATP1B1 TM10 Controls Selective Dichlorofluorescein Transpor

  2026-09-15

  The reference study combines OATP1B1/OATP1B3 chimeras with targeted mutagenesis to show that transmembrane domain 10, particularly Q541 and L545, governs selective dichlorofluorescein uptake. Its substrate-dependent results refine models of OATP1B1 recognition and provide a framework for interpreting transporter-mediated drug interactions.

• Carrier-Free Triterpene Prodrug for OSCC

  2026-09-15

  The reference study develops a carrier-free, self-assembled prodrug that combines glycyrrhetinic acid and ginsenoside Rh2 through a ROS-responsive thioketal design for targeted oral squamous cell carcinoma chemotherapy. Its self-boosting mechanism links tumor-associated oxidative stress to drug release, further ROS generation, and synergistic apoptotic injury, while avoiding a conventional nanocarrier.

• AG-490: JAK2/STAT6 Assay Workflows

  2026-09-14

  Use AG-490, also called Tyrphostin B42, as a pharmacological probe for testing whether exosome-driven macrophage polarization depends on JAK2 signaling. This workflow combines dose-aware pathway analysis, exosomal SNORD52 biology, and controls that help distinguish JAK2/STAT6 effects from EGFR, ErbB2, or cytotoxic responses.

• Indomethacin: Practical Protocols for Inflammation Research

  2026-09-14

  Indomethacin provides a defined chemical probe for comparing cyclooxygenase activity and exploring inflammation, PPAR-linked transcription, lipid metabolism, and membrane behavior. This guide supports stock preparation, assay controls, and interpretation, but it should not be treated as a universal dosing protocol or as evidence of mechanism in a model that has not been independently validated.

8608 records 1/574 page Next 12345 下5页 Last page